These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 937009)

  • 1. L-DOPA metabolism in the rat exocrine pancreas - a biochemical study.
    Alm P; Petterson GB
    Acta Pharm Suec; 1976; 13(2):167-74. PubMed ID: 937009
    [No Abstract]   [Full Text] [Related]  

  • 2. Amines and the rat exocrine pancreas: (1). Effects of receptor blockers on turnover of L-dopa.
    Mori J; Satoh Y; Hashimoto M; Honda F
    Jpn J Pharmacol; 1979 Dec; 29(6):899-911. PubMed ID: 44324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemical studies on the metabolism of L-DOPA and some related substances in the exocrine pancreas.
    Alm P; Ehinger B; Falck B
    Acta Physiol Scand; 1969; 76(1):106-20. PubMed ID: 5307270
    [No Abstract]   [Full Text] [Related]  

  • 4. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease.
    Melamed E; Hefti F; Liebman J; Schlosberg AJ; Wurtman RJ
    Nature; 1980 Feb; 283(5749):772-4. PubMed ID: 6101905
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the activation of dopa decarboxylase and other cytoplasmic liver enzymes by inducers of microsomal enzymes].
    Palm D; Ernzerhoff C; Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(4):352-71. PubMed ID: 4174080
    [No Abstract]   [Full Text] [Related]  

  • 8. 3-O-methyldopa blocks dopa metabolism in rat corpus striatum.
    Reches A; Fahn S
    Ann Neurol; 1982 Sep; 12(3):267-71. PubMed ID: 7137962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D; Abercrombie ED; Zigmond MJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple roles of the active site lysine of Dopa decarboxylase.
    Bertoldi M; Voltattorni CB
    Arch Biochem Biophys; 2009 Aug; 488(2):130-9. PubMed ID: 19580779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) mediates release of l-3,4-dihydroxyphenylalanine (l-DOPA) and inhibition of l-DOPA decarboxylase in the rat striatum: a microdialysis study.
    Foster SB; Wrona MZ; Han J; Dryhurst G
    Chem Res Toxicol; 2003 Oct; 16(10):1372-84. PubMed ID: 14565778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the metabolism of 14C-dopa in the hepatopancreas of decapod crustacean Upogebia littoralis.
    Marmaras VJ; Fragoulis EG
    Comp Gen Pharmacol; 1971 Mar; 2(5):52-8. PubMed ID: 5162655
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of pilocarpine on L-dopa turnover in the exocrine rat pancreas.
    Alm P
    Acta Physiol Scand; 1971 Oct; 83(2):269-77. PubMed ID: 5114364
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of a new system of amine-storing cells in the gastric mucosa of the rat.
    Håkanson R; Lilja B; Owman C
    Eur J Pharmacol; 1967 May; 1(3):188-99. PubMed ID: 6058905
    [No Abstract]   [Full Text] [Related]  

  • 17. Exposure to light accelerates the formation of dopamine from exogenous L-dopa in the rat retina.
    Xu JA; Hadjiconstantinou M; Neff NH
    J Ocul Pharmacol; 1985; 1(2):177-81. PubMed ID: 3880074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amines and the rat exocrine pancreas: (2) Effects of receptor blockers on turnover of L-5HTP.
    Mori J; Hashimoto M; Mukumoto S; Honda F
    Jpn J Pharmacol; 1979 Dec; 29(6):913-21. PubMed ID: 44325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of reserpine and prenylamine on the L-dopa turnover in the rat exocrine pancreas.
    Alm P; Ehinger B; Falck B; Nordgren L
    Eur J Pharmacol; 1971 Oct; 16(2):192-200. PubMed ID: 5161258
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorescence microscopy of the 5-HTP turnover in the exocrine pancreas of mice and rats.
    Alm P
    Z Zellforsch Mikrosk Anat; 1969; 96(2):212-21. PubMed ID: 5305660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.